Search
Glycerol phenylbutyrate
go.drugbank.com/drugs/DB08909ApprovedInvestigationalGlycerol phenylbutyrate is a nitrogen-binding agent. Chemically, it is a triglyceride in which three molecules of phenylbutyrate are linked to a glycerol backbone. FDA approved on February 1, 2013.
Brolucizumab
go.drugbank.com/drugs/DB14864ApprovedInvestigational[L9089] Brolucizumab was granted FDA approval in October 2019.[L9089] … Brolucizumab, also known as RTH258 or ESBA1008,[A187211] is a monoclonal antibody indicated to treat neovascular age related macular degeneration.
Dinutuximab
go.drugbank.com/drugs/DB09077ApprovedInvestigationalDespite a high clinical response seen after first-line treatment, the complete eradication of neuroblastoma is rarely achieved and the majority of patients with advanced disease suffer a relapse. … neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality therapy.
Fuzapladib
go.drugbank.com/drugs/DB19478ExperimentalFuzapladib has a monoisotopic molecular weight of 379.12 Da. … Fuzapladib is a small molecule drug. The usage of the INN stem '-pladib' in the name indicates that Fuzapladib is a phospholipase A2 inhibitor.
Categories: Phospholipases A, antagonists & inhibitorsUmibecestat
go.drugbank.com/drugs/DB19898ExperimentalUmibecestat has a monoisotopic molecular weight of 513.08 Da. … Umibecestat is a small molecule drug. The usage of the INN stem '-becestat' in the name indicates that Umibecestat is a beta secretase inhibitor.
Zaloglanstat
go.drugbank.com/drugs/DB21495ExperimentalZaloglanstat has a monoisotopic molecular weight of 452.12 Da. … Zaloglanstat is a small molecule drug. The usage of the INN stem '-glanstat' in the name indicates that Zaloglanstat is a prostaglandin synthase inhibitor.
Zevaquenabant
go.drugbank.com/drugs/DB21590ExperimentalZevaquenabant has a monoisotopic molecular weight of 547.11 Da. … Zevaquenabant is a small molecule drug. The usage of the INN stem '-nabant' in the name indicates that Zevaquenabant is a cannabinoid receptor antagonist.
Setidegrasib
go.drugbank.com/drugs/DB21670InvestigationalSetidegrasib has a monoisotopic molecular weight of 1116.48 Da. … Setidegrasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Setidegrasib is a Ras protein inhibitor.